Screening Marine Microbial Metabolites as Promising Inhibitors of <i>Borrelia garinii</i>: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment.

Authors:
Basharat Z; Sattar S; Bahauddin AA; Al Mouslem AK; Alotaibi G.

Journal:
Biomed Res Int

Publication Year: 2024

DOI:
10.1155/2024/9997082

PMCID:
PMC10919988

PMID:
38456098

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Biomed Res Int

Detailed journal information not available.

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

4/6

66.7% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Evidence found in paper:

"the top threading templates by i-tasser included adi from group a streptococcus (pdb id: 4bof) enolase from mycoplasma pneumoniae (pdb id: 7e2q) adi from mycoplasmopsis arginini (pdb id: 1s9r; 1lxy) and the structural protein vp3 from bombyx mori cypovirus1 (pdb id: 7whp)."

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflict of interest."

Funding Disclosure

Evidence found in paper:

"Shaqra University"

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025